{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:16:01Z","timestamp":1793153761147,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013479","name":"Bay Area Lyme Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013479","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014731","name":"Global Lyme Alliance","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although prior research has established sex and menopausal status-based differences in immune response, susceptibility, and severity to a variety of pathogens, their relevance in early Lyme disease is understudied. We examined the clinical and serologic presentation of patients with early Lyme disease, stratified first by sex then by menopausal status. We also explored the hypothesis that males would present with more severe early Lyme disease. In this prospective cohort study from the Mid-Atlantic US, 243 adult, antibiotic-na\u00efve patients were enrolled with a diagnostic erythema migrans rash present. Demographic, physical exam, symptom, laboratory, and two-tier serology data were collected at a baseline, and a post-treatment visit 3 weeks later. Lyme disease severity was operationalized through six indicators: rash size, number of acute symptoms, dermatologic dissemination, positive serology, liver function elevation, and elevated neutrophil-lymphocyte ratio. Unadjusted group comparisons and multivariate regression adjusting for potential confounders were used to assess difference. In logistic models adjusted for age, Lyme disease duration, systemic steroid use, and co-morbid thyroid disease, males had higher odds of testing two-tier positive (OR\u2009=\u20091.77 [1.03, 3.04],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.039). This difference was more pronounced between males and pre-menopausal females (OR\u2009=\u20092.93 [1.26\u20136.79],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.012) and no significant difference was found comparing males to post-menopausal females. In ordinal logistic models with Lyme disease severity as the outcome adjusted for age and Lyme disease duration, males had higher odds of being in a higher disease severity score category (OR\u2009=\u20091.94 [1.20,3.15],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.028); again, particularly in comparison to pre-menopausal females (OR\u2009=\u20092.26 [1.13,4.58],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.044). Heart palpitations (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.023), vomiting (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.007), and photophobia (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.057) trended towards higher reporting among females, while sleep difficulty (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.010) was higher among males. No differences were found on non-dermatologic components of the physical exam.\u00a0We found sex and menopausal status to be relevant in accounting for variability in two-tier serologic status and severity of early Lyme disease in a well-characterized group of patients. Lower rates of seroreactivity among females is unexpected but may be consistent with lower acute severity of disease. Our clinical findings underscore the need for additional research to understand possible contributing biologic and\/or social behavioral factors, as well as their impact on timely diagnosis and post-treatment conditions.\n                  <\/jats:p>","DOI":"10.1007\/s10238-026-02063-0","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:05:18Z","timestamp":1770447918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex and menopause-based differences in presentation of early Lyme disease: A prospective cohort study"],"prefix":"10.1007","volume":"26","author":[{"given":"Alison W.","family":"Rebman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"2063_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.90","volume":"2","author":"AC Steere","year":"2016","unstructured":"Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, et al. Lyme borreliosis. Nat Rev Dis Primers. 2016;2:16090. https:\/\/doi.org\/10.1038\/nrdp.2016.90.","journal-title":"Nat Rev Dis Primers"},{"key":"2063_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.idc.2022.03.004","volume":"36","author":"P Mead","year":"2022","unstructured":"Mead P. Epidemiology of Lyme disease. Infect Dis Clin North Am. 2022;36:495\u2013521. https:\/\/doi.org\/10.1016\/j.idc.2022.03.004.","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"2063_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00018-19","volume":"34","author":"JA Branda","year":"2021","unstructured":"Branda JA, Steere AC. Laboratory diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2021;34(2):1\u201345. https:\/\/doi.org\/10.1128\/CMR.00018-19.","journal-title":"Clin Microbiol Rev"},{"key":"2063_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00057","author":"AW Rebman","year":"2020","unstructured":"Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med Lausanne. 2020. https:\/\/doi.org\/10.3389\/fmed.2020.00057.","journal-title":"Front Med Lausanne"},{"key":"2063_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL, Nature Publishing Group. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"key":"2063_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIU159","author":"J Van Lunzen","year":"2014","unstructured":"Van Lunzen J, Altfeld M. Sex differences in infectious diseases-common but neglected. J Infect Dis. 2014. https:\/\/doi.org\/10.1093\/INFDIS\/JIU159.","journal-title":"J Infect Dis"},{"key":"2063_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00283-22","author":"SP Dias","year":"2022","unstructured":"Dias SP, Brouwer MC, Van De Beek D, American Society for Microbiology (ASM). Sex and gender differences in bacterial infections. Infect Immun. 2022. https:\/\/doi.org\/10.1128\/IAI.00283-22.","journal-title":"Infect Immun"},{"issue":"2","key":"2063_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1005374","volume":"12","author":"LG vom Steeg","year":"2016","unstructured":"vom Steeg LG, Klein SL, Public Library of Science. SeXX matters in infectious disease pathogenesis. PLoS Pathog. 2016;12(2):e1005374. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1005374.","journal-title":"PLoS Pathog"},{"key":"2063_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.maturitas.2010.08.003","volume":"67","author":"CM Gameiro","year":"2010","unstructured":"Gameiro CM, Rom\u00e3o F, Castelo-Branco C. Menopause and aging: changes in the immune system\u2013a review. Maturitas. 2010;67:316\u201320. https:\/\/doi.org\/10.1016\/j.maturitas.2010.08.003.","journal-title":"Maturitas"},{"key":"2063_CR10","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1096\/fj.10-160911","volume":"24","author":"EJ Goetzl","year":"2010","unstructured":"Goetzl EJ, Huang M-C, Kon J, Patel K, Schwartz JB, Fast K, et al. Gender specificity of altered human immune cytokine profiles in aging. FASEB J. 2010;24:3580\u20139. https:\/\/doi.org\/10.1096\/fj.10-160911.","journal-title":"FASEB J"},{"key":"2063_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/ACEL.12326","volume":"14","author":"C Giefing-Kr\u00f6ll","year":"2015","unstructured":"Giefing-Kr\u00f6ll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14:309\u201321. https:\/\/doi.org\/10.1111\/ACEL.12326.","journal-title":"Aging Cell"},{"key":"2063_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAUT.2011.11.013","author":"LM Pennell","year":"2012","unstructured":"Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J autoimmun [Internet]. J Autoimmun. 2012. https:\/\/doi.org\/10.1016\/J.JAUT.2011.11.013. [cited 2025 Jan 6];38.","journal-title":"J Autoimmun"},{"key":"2063_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/S15010-021-01590-0","volume":"49","author":"AW Rebman","year":"2021","unstructured":"Rebman AW, Yang T, Mihm EA, Novak CB, Yoon I, Powell D, et al. The presenting characteristics of erythema migrans vary by age, sex, duration, and body location. Infect [Internet] Infect. 2021;49:685\u201392. https:\/\/doi.org\/10.1007\/S15010-021-01590-0. [cited 2021 Oct 27];.","journal-title":"Infect [Internet] Infect"},{"key":"2063_CR14","doi-asserted-by":"publisher","DOI":"10.4269\/AJTMH.22-0437","author":"AW Rebman","year":"2023","unstructured":"Rebman AW, Yang T, Yoon I, Powell D, Geller SA, Aucott JN. Initial presentation and time to treatment in early Lyme disease. Am J Trop Med Hyg [Internet] Am J Trop Med Hyg. 2023. https:\/\/doi.org\/10.4269\/AJTMH.22-0437. [cited 2023 Feb 12].","journal-title":"Am J Trop Med Hyg [Internet] Am J Trop Med Hyg"},{"key":"2063_CR15","first-page":"590","volume":"44","author":"Centers for Disease Control and Pre","year":"1995","unstructured":"Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the second National conference on serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep [Internet]. 1995;44:590\u20131. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00038469.htm.","journal-title":"MMWR Morb Mortal Wkly Rep [Internet]"},{"key":"2063_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2024.1454858","author":"AW Rebman","year":"2024","unstructured":"Rebman AW, Yang T, Zenilman JM, Soloski MJ, Aucott JN. A sex-based analysis of complete blood count features during acute, untreated Lyme disease. Front Med Lausanne. 2024. https:\/\/doi.org\/10.3389\/FMED.2024.1454858.","journal-title":"Front Med Lausanne"},{"key":"2063_CR17","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6622a1","author":"AM Schwartz","year":"2017","unstructured":"Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ, Centers for Disease Control and Prevention (CDC). Surveillance for Lyme disease - United States, 2008\u20132015. MMWR Surveill Summ. 2017. https:\/\/doi.org\/10.15585\/mmwr.ss6622a1.","journal-title":"MMWR Surveill Summ"},{"key":"2063_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2023.47184","volume":"6","author":"SJ Starke","year":"2023","unstructured":"Starke SJ, Rebman AW, Miller J, Yang T, Aucott JN. Time to diagnosis and treatment of Lyme disease by patient race. JAMA Netw Open. 2023;6:E2347184. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2023.47184.","journal-title":"JAMA Netw Open"},{"key":"2063_CR19","doi-asserted-by":"publisher","first-page":"e64110","DOI":"10.1371\/journal.pone.0064110","volume":"8","author":"F Strle","year":"2013","unstructured":"Strle F, Wormser GP, Mead P, Dhaduvai K, Longo MV, Adenikinju O, et al. Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis. PLoS One [Internet] Public Libr Sci. 2013;8:e64110. https:\/\/doi.org\/10.1371\/journal.pone.0064110.","journal-title":"PLoS One [Internet] Public Libr Sci"},{"key":"2063_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFX254","author":"NA Kwit","year":"2018","unstructured":"Kwit NA, Nelson CA, Max R, Mead PS, Oxford University Press. Risk factors for clinician-diagnosed Lyme arthritis, facial palsy, carditis, and meningitis in patients from high-incidence states. Open Forum Infect Dis. 2018. https:\/\/doi.org\/10.1093\/OFID\/OFX254.","journal-title":"Open Forum Infect Dis"},{"key":"2063_CR21","doi-asserted-by":"publisher","unstructured":"Johnson L, Shapiro M, Janicki S, Mankoff J, Stricker RB, Dove Medical Press Ltd. Does biological sex matter in Lyme disease? The need for sex-disaggregated data in persistent illness. Int J Gen Med. 2023:2557. https:\/\/doi.org\/10.2147\/IJGM.S406466.","DOI":"10.2147\/IJGM.S406466"},{"issue":"5","key":"2063_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","volume":"28","author":"J Choutka","year":"2022","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A, Nature Publishing Group. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911\u201323. https:\/\/doi.org\/10.1038\/s41591-022-01810-6.","journal-title":"Nat Med"},{"key":"2063_CR23","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1001\/ARCHINTE.163.13.1530","volume":"163","author":"M Reyes","year":"2003","unstructured":"Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. 2003;163:1530\u20136. https:\/\/doi.org\/10.1001\/ARCHINTE.163.13.1530.","journal-title":"Arch Intern Med"},{"key":"2063_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/J.IJID.2020.07.076","volume":"99","author":"A Ortolan","year":"2020","unstructured":"Ortolan A, Lorenzin M, Felicetti M, Doria A, Ramonda R. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. Int J Infect Dis [Internet] Elsevier B V. 2020;99:496. https:\/\/doi.org\/10.1016\/J.IJID.2020.07.076. [cited 2025 Nov 25];.","journal-title":"Int J Infect Dis [Internet] Elsevier B V"},{"key":"2063_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4415\/ANN_16_02_11","volume":"52","author":"A Ruggierii","year":"2016","unstructured":"Ruggierii A, Anticoli S, D\u2019ambrosio A, Giordani L, Mora M. The influence of sex and gender on immunity, infection and vaccination. Ann Ist Super Sanita. 2016;52:198\u2013204. https:\/\/doi.org\/10.4415\/ANN_16_02_11.","journal-title":"Ann Ist Super Sanita"},{"key":"2063_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/ZPH.12699","volume":"67","author":"AM Schwartz","year":"2020","unstructured":"Schwartz AM, Shankar MB, Kugeler KJ, Max RJ, Hinckley AF, Meltzer MI, et al. Epidemiology and cost of Lyme disease-related hospitalizations among patients with employer-sponsored health insurance-United States, 2005\u20132014. Zoonoses Public Health. 2020;67:407\u201315. https:\/\/doi.org\/10.1111\/ZPH.12699.","journal-title":"Zoonoses Public Health"},{"key":"2063_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/J.COPHYS.2018.03.010","volume":"6","author":"AL Fink","year":"2018","unstructured":"Fink AL, Klein SL, Elsevier Ltd. The evolution of greater humoral immunity in females than males: implications for vaccine efficacy. Curr Opin Physiol. 2018;6:16. https:\/\/doi.org\/10.1016\/J.COPHYS.2018.03.010.","journal-title":"Curr Opin Physiol"},{"key":"2063_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.genm.2010.08.002","volume":"7","author":"A Schwarzwalder","year":"2010","unstructured":"Schwarzwalder A, Schneider MF, Lydecker A, Aucott JN. Sex differences in the clinical and serologic presentation of early Lyme disease: results from a retrospective review. Gend Med [Internet]. 2010;7:320\u20139. https:\/\/doi.org\/10.1016\/j.genm.2010.08.002.","journal-title":"Gend Med [Internet]"},{"key":"2063_CR29","doi-asserted-by":"publisher","unstructured":"Li Y, Matsushita F, Chen Z, Jones RS, Bare LA, Petersen JM, et al. Sex- and age-specific Lyme disease testing patterns in the United States, 2019 and 2022. Public Health Rep. 2025;00333549251314419. https:\/\/doi.org\/10.1177\/00333549251314419.","DOI":"10.1177\/00333549251314419"},{"key":"2063_CR30","doi-asserted-by":"publisher","unstructured":"Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020:6141\u201350. https:\/\/doi.org\/10.1172\/JCI142004.","DOI":"10.1172\/JCI142004"},{"key":"2063_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7326\/0003-4819-142-9-200505030-00011","volume":"142","author":"GP Wormser","year":"2005","unstructured":"Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D, et al. Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med. 2005;142:751\u20135.","journal-title":"Ann Intern Med"},{"key":"2063_CR32","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/CVI.00109-08","volume":"15","author":"GP Wormser","year":"2008","unstructured":"Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME. Impact of clinical variables on borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Clin Vaccine Immunol [Internet]. 2008;15:1519\u201322. https:\/\/doi.org\/10.1128\/CVI.00109-08.","journal-title":"Clin Vaccine Immunol [Internet]"},{"key":"2063_CR33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/IAI.01216-09","volume":"78","author":"VM Benoit","year":"2010","unstructured":"Benoit VM, Petrich A, Alugupalli KR, Marty-Roix R, Moter A, Leong JM, et al. Genetic control of the innate immune response to borrelia hermsii influences the course of relapsing fever in inbred strains of mice. Infect Immun [Internet]. 2010;78:586\u201394. https:\/\/doi.org\/10.1128\/IAI.01216-09.","journal-title":"Infect Immun [Internet]"},{"key":"2063_CR34","doi-asserted-by":"publisher","unstructured":"Koloski CW, Hurry G, Foley-Eby A, Adam H, Goldstein S, Zvionow P, et al. Male C57BL\/6J mice have higher presence and abundance of Borrelia burgdorferi in their ventral skin compared to female mice. Ticks Tick-Borne Dis. 2024. https:\/\/doi.org\/10.1016\/j.ttbdis.2024.102308.","DOI":"10.1016\/j.ttbdis.2024.102308"},{"key":"2063_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1365-2567.2006.02360.x","volume":"118","author":"S Jarefors","year":"2006","unstructured":"Jarefors S, Bennet L, You E, Forsberg P, Ekerfelt C, Berglund J, et al. Lyme borreliosis reinfection: might it be explained by a gender difference in immune response? Immunol [Internet]. 2006;118:224\u201332. https:\/\/doi.org\/10.1111\/j.1365-2567.2006.02360.x.","journal-title":"Immunol [Internet]"},{"key":"2063_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/vbz.2006.0533","volume":"7","author":"L Bennet","year":"2007","unstructured":"Bennet L, Stjernberg L, Berglund J. Effect of gender on clinical and epidemiologic features of Lyme borreliosis. Vector Borne Zoonotic Dis [Internet]. 2007;7:34\u201341. https:\/\/doi.org\/10.1089\/vbz.2006.0533.","journal-title":"Vector Borne Zoonotic Dis [Internet]"},{"key":"2063_CR37","doi-asserted-by":"publisher","first-page":"107883","DOI":"10.1016\/J.MATURITAS.2023.107883","volume":"179","author":"CT Erel","year":"2024","unstructured":"Erel CT, Ozcivit Erkan IB, Inan NG, Hamzaoglu Canbolat K, Alkan S, Konukoglu D, et al. The impact of menopause and serum DHEA-S level on the severity of Covid-19. Maturitas Elsevier. 2024;179:107883. https:\/\/doi.org\/10.1016\/J.MATURITAS.2023.107883.","journal-title":"Maturitas Elsevier"},{"key":"2063_CR38","doi-asserted-by":"publisher","unstructured":"Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J et al. Potential influence of menstrual status and sex hormones on female severe acute respiratory syndrome coronavirus 2 infection: A cross-sectional multicenter study in Wuhan, China. Clin infect dis [Internet]. Clin Infect Dis; 2021 [cited 2024 May 28];72:E240\u20138. https:\/\/doi.org\/10.1093\/CID\/CIAA1022","DOI":"10.1093\/CID\/CIAA1022"},{"key":"2063_CR39","first-page":"454","volume":"21","author":"ES Asch","year":"1994","unstructured":"Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol [Internet]. 1994;21:454\u201361. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8006888.","journal-title":"J Rheumatol [Internet]"},{"key":"2063_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","volume":"121","author":"NA Shadick","year":"1994","unstructured":"Shadick NA, Phillips CB, Logigian EL, Steere AC, Kaplan RF, Berardi VP, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med [Internet]. 1994;121:560\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8085687.","journal-title":"Ann Intern Med [Internet]"},{"key":"2063_CR41","unstructured":"Food and Drug Administration. FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses [Internet]. 2019 [cited 2025 Mar 6]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-new-indications-existing-lyme-disease-tests-may-help-streamline-diagnoses. Accessed 6 Mar 2025."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02063-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02063-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02063-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:39:13Z","timestamp":1770687553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02063-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02063-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JA has received consulting fees from the Pfizer North America Lyme Disease Vaccine Advisory Board and the Tarsus Pharmaceuticals Inc. Lyme Disease Advisory Board. JA serves on the Scientific Advisory Board for the Stephen and Alexandra Cohen Foundation. JA has been issued the following patent: \u201cElevated CCL19 after completion of therapy for acute Lyme disease identifies patients at risk for development of post-treatment Lyme disease syndrome who will benefit from further antibiotic therapy. Patent approved US patent application (16\/058316) and has the following patent pending:\u201d Gene-Expression-Based Identification of Early Lyme Disease.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of the Johns Hopkins University School of Medicine approved the studies from which these data were drawn (NA_00011170, NA_00071455, IRB00272446), and no study activities were performed prior to obtaining written, informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"139"}}